<?xml version="1.0" encoding="ISO-8859-1"?><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<front>
<journal-meta>
<journal-id>1870-7203</journal-id>
<journal-title><![CDATA[Acta médica Grupo Ángeles]]></journal-title>
<abbrev-journal-title><![CDATA[Acta méd. Grupo Ángeles]]></abbrev-journal-title>
<issn>1870-7203</issn>
<publisher>
<publisher-name><![CDATA[Grupo Ángeles, Servicios de Salud]]></publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id>S1870-72032026000200153</article-id>
<article-id pub-id-type="doi">10.35366/122622</article-id>
<title-group>
<article-title xml:lang="es"><![CDATA[Embolización de arterias uterinas: una estrategia exitosa para el manejo del sangrado uterino en cáncer cervicouterino avanzado]]></article-title>
<article-title xml:lang="en"><![CDATA[Uterine artery embolization: a successful strategy for the management of uterine bleeding in advanced cervical cancer]]></article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Hernández Juárez]]></surname>
<given-names><![CDATA[Roberto]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
<xref ref-type="aff" rid="Aaf"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Ríos Reina]]></surname>
<given-names><![CDATA[José Luis]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Alvarado Estrada]]></surname>
<given-names><![CDATA[Eliel Anastasio]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
<contrib contrib-type="author">
<name>
<surname><![CDATA[Arias Renteria]]></surname>
<given-names><![CDATA[Marcel]]></given-names>
</name>
<xref ref-type="aff" rid="Aff"/>
</contrib>
</contrib-group>
<aff id="Af1">
<institution><![CDATA[,Universidad la Salle Facultad Mexicana de Medicina Departamento de Radiología e Imagen]]></institution>
<addr-line><![CDATA[León Guanajuato]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af2">
<institution><![CDATA[,Hospital Angeles Mocel departamento radiología e imagen ]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>México</country>
</aff>
<aff id="Af3">
<institution><![CDATA[,Universidad la Salle Facultad Mexicana de Medicina Departamento de Radiología e Imagen]]></institution>
<addr-line><![CDATA[Ciudad de México ]]></addr-line>
<country>Mexico</country>
</aff>
<aff id="Af4">
<institution><![CDATA[,Universidad de Guadalajara Facultad de Medicina ]]></institution>
<addr-line><![CDATA[Guadalajara Jalisco]]></addr-line>
<country>Mexico</country>
</aff>
<pub-date pub-type="pub">
<day>00</day>
<month>04</month>
<year>2026</year>
</pub-date>
<pub-date pub-type="epub">
<day>00</day>
<month>04</month>
<year>2026</year>
</pub-date>
<volume>24</volume>
<numero>2</numero>
<fpage>153</fpage>
<lpage>156</lpage>
<copyright-statement/>
<copyright-year/>
<self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_arttext&amp;pid=S1870-72032026000200153&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_abstract&amp;pid=S1870-72032026000200153&amp;lng=en&amp;nrm=iso"></self-uri><self-uri xlink:href="http://www.scielo.org.mx/scielo.php?script=sci_pdf&amp;pid=S1870-72032026000200153&amp;lng=en&amp;nrm=iso"></self-uri><abstract abstract-type="short" xml:lang="es"><p><![CDATA[Resumen: El carcinoma cervicouterino sigue siendo una de las principales causas de morbilidad y mortalidad mundial. En etapas avanzadas, el sangrado transvaginal es una complicación grave que afecta la calidad de vida y el pronóstico. Este reporte presenta el caso de una paciente de 39 años con carcinoma cervicouterino epidermoide estadio IV A, quien presentó sangrado transvaginal intenso, anemia y choque hipovolémico. Se realizó una embolización de arterias uterinas (EAU) exitosa para controlar el sangrado. Aunque los resultados fueron positivos, se necesita más investigación clínica para establecer protocolos y evaluar su aplicabilidad en carcinoma cervicouterino avanzado.]]></p></abstract>
<abstract abstract-type="short" xml:lang="en"><p><![CDATA[Abstract: Cervical cancer (CC) remains one of the leading causes of morbidity and mortality worldwide. In advanced stages, transvaginal bleeding is a serious complication that affects both the quality of life and the prognosis. This case report presents a 39-year-old patient with stage IV A squamous cell carcinoma of the cervix, who experienced severe transvaginal bleeding, anemia, and hypovolemic shock. Uterine artery embolization (UAE) was successfully performed to control the bleeding. While the results were positive, further clinical research and controlled studies are needed to establish protocols and assess the applicability of UAE in advanced CC patients.]]></p></abstract>
<kwd-group>
<kwd lng="es"><![CDATA[radiología intervencionista]]></kwd>
<kwd lng="es"><![CDATA[embolización de la arteria uterina]]></kwd>
<kwd lng="es"><![CDATA[cáncer cérvico uterino]]></kwd>
<kwd lng="es"><![CDATA[hemorragia vaginal]]></kwd>
<kwd lng="en"><![CDATA[interventional radiology]]></kwd>
<kwd lng="en"><![CDATA[uterine artery embolization]]></kwd>
<kwd lng="en"><![CDATA[cervical cancer]]></kwd>
<kwd lng="en"><![CDATA[vaginal hemorrhage]]></kwd>
</kwd-group>
</article-meta>
</front><back>
<ref-list>
<ref id="B1">
<label>1</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Sung]]></surname>
<given-names><![CDATA[H]]></given-names>
</name>
<name>
<surname><![CDATA[Ferlay]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
<name>
<surname><![CDATA[Siegel]]></surname>
<given-names><![CDATA[RL]]></given-names>
</name>
<name>
<surname><![CDATA[Laversanne]]></surname>
<given-names><![CDATA[M]]></given-names>
</name>
<name>
<surname><![CDATA[Soerjomataram]]></surname>
<given-names><![CDATA[I]]></given-names>
</name>
<name>
<surname><![CDATA[Jemal]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries]]></article-title>
<source><![CDATA[CA Cancer J Clin]]></source>
<year>2021</year>
<volume>71</volume>
<numero>3</numero>
<issue>3</issue>
<page-range>209-49</page-range></nlm-citation>
</ref>
<ref id="B2">
<label>2</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Bhatla]]></surname>
<given-names><![CDATA[N]]></given-names>
</name>
<name>
<surname><![CDATA[Aoki]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Sharma]]></surname>
<given-names><![CDATA[DN]]></given-names>
</name>
<name>
<surname><![CDATA[Sankaranarayanan]]></surname>
<given-names><![CDATA[R]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Cancer of the cervix uteri: 2021 update]]></article-title>
<source><![CDATA[Int J Gynecol Obstet]]></source>
<year>2021</year>
<volume>155</volume>
<numero>^s1</numero>
<issue>^s1</issue>
<supplement>1</supplement>
<page-range>28-44</page-range></nlm-citation>
</ref>
<ref id="B3">
<label>3</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Munteanu]]></surname>
<given-names><![CDATA[O]]></given-names>
</name>
<name>
<surname><![CDATA[Secara]]></surname>
<given-names><![CDATA[D]]></given-names>
</name>
<name>
<surname><![CDATA[Neamtu]]></surname>
<given-names><![CDATA[MN]]></given-names>
</name>
<name>
<surname><![CDATA[Baros]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dimitriade]]></surname>
<given-names><![CDATA[A]]></given-names>
</name>
<name>
<surname><![CDATA[Dorobat]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Our experience in using the endovascular therapy in the management of hemorrhages in obstetrics and gynecology]]></article-title>
<source><![CDATA[Diagnostics (Basel)]]></source>
<year>2022</year>
<volume>12</volume>
<numero>6</numero>
<issue>6</issue>
<page-range>1436</page-range></nlm-citation>
</ref>
<ref id="B4">
<label>4</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Dariushnia]]></surname>
<given-names><![CDATA[SR]]></given-names>
</name>
<name>
<surname><![CDATA[Nikolic]]></surname>
<given-names><![CDATA[B]]></given-names>
</name>
<name>
<surname><![CDATA[Stokes]]></surname>
<given-names><![CDATA[LS]]></given-names>
</name>
<name>
<surname><![CDATA[Spies]]></surname>
<given-names><![CDATA[JB]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Quality improvement guidelines for uterine artery embolization for symptomatic leiomyomata]]></article-title>
<collab>Society of Interventional Radiology Standards of Practice Committee</collab>
<source><![CDATA[J Vasc Interv Radiol]]></source>
<year>2014</year>
<volume>25</volume>
<numero>11</numero>
<issue>11</issue>
<page-range>1737-47</page-range></nlm-citation>
</ref>
<ref id="B5">
<label>5</label><nlm-citation citation-type="journal">
<person-group person-group-type="author">
<name>
<surname><![CDATA[Lipman]]></surname>
<given-names><![CDATA[J]]></given-names>
</name>
</person-group>
<article-title xml:lang=""><![CDATA[Uterine artery embolization in the office-based lab]]></article-title>
<source><![CDATA[Tech Vasc Interv Radiol]]></source>
<year>2024</year>
<volume>27</volume>
<numero>1</numero>
<issue>1</issue>
</nlm-citation>
</ref>
</ref-list>
</back>
</article>
